Ryan Specialty FY 2025 total revenue rises 21.3% to USD 3.1bn

Reuters
02/21
<a href="https://laohu8.com/S/RYAN">Ryan Specialty</a> FY 2025 total revenue rises 21.3% to USD 3.1bn

Ryan Specialty reported FY 2025 total revenue of USD 3.05 billion, up 21.3%, including net commissions and fees of USD 2.99 billion. FY 2025 net income was USD 214.2 million, while adjusted EBITDAC was USD 966.7 million with an adjusted EBITDAC margin of 31.7%. Organic revenue growth for FY 2025 was 10.1%. The group said 78% of its premiums were placed in the E&S market in FY 2025 and reported 96% producer retention. Ryan Specialty completed 63 acquisitions since founding and said it acquired USD 128 million of revenue in 2025. On capital returns, it said it increased its regular quarterly dividend 8% to USD 0.13 per share in February 2026 and announced an inaugural USD 300 million share repurchase authorization. As of December 31, 2025, net leverage on a credit basis was 3.2x, and it reported Moody’s (Ba3), S&P (BB-), and Fitch (BB+) ratings with stable outlooks.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ryan Specialty Holdings Inc. published the original content used to generate this news brief on February 20, 2026, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10